Diabetes Devices
The U.S. diabetes device market continues to expand as diabetes prevalence rises and demand for continuous glucose monitoring, insulin delivery, and digital health solutions increases. Our research delivers comprehensive analysis of market dynamics, emerging technologies, competitive positioning, and future growth opportunities.
The U.S. Type 1 Diabetes Care Devices Market is projected to reach USD 29.97 billion by 2035, driven by CGM, insulin pumps, automated insulin delivery, and connected diabetes management technologies.
Read Report Details
The U.S. Diabetes Device Interoperability Market is projected to grow from USD 6.72 billion in 2025 to USD 28.15 billion by 2035 at a 15.40% CAGR, driven by interoperable CGMs, automated insulin delivery, connected pumps, smart insulin systems, and clinical data integration.
Read Report Details
The U.S. Personalized Diabetes Care Devices Market is projected to grow from USD 11.72 billion in 2025 to USD 36.40 billion by 2035, driven by CGM, automated insulin delivery, smart injection systems, interoperability, and personalized glucose management.
Read Report Details
The U.S. Remote Diabetes Monitoring Devices Market is projected to grow from $8.15B in 2025 to $34.14B by 2035 at a 15.40% CAGR.
Read Report Details
The U.S. AI-Enabled Diabetes Care Devices Market is projected to grow from USD 7.25 billion in 2025 to USD 35.62 billion by 2035 at a 17.26% CAGR, driven by AI-enabled CGM, automated insulin delivery, predictive glucose analytics, and intelligent dosing technologies.
Read Report Details
The U.S. Wearable Diabetes Care Devices Market is projected to grow from USD 12.48 billion in 2025 to USD 38.92 billion by 2035 at a 12.05% CAGR, driven by CGM, automated insulin delivery, wearable pumps, OTC glucose sensing, and connected diabetes care.
Read Report Details
U.S. digital diabetes care devices are projected to grow from USD 11.84B in 2025 to USD 31.67B by 2035 at a 10.34% CAGR.
Read Report Details
The U.S. Connected Diabetes Care Devices Market is projected to grow from USD 10.35 billion in 2025 to USD 37.70 billion by 2035 at a 13.80% CAGR, driven by CGM expansion, automated insulin delivery, connected injection systems, and wider adoption across type 2 diabetes care.
Read Report Details
The U.S. Home Diabetes Care Devices Market is projected to grow from USD 12.30 billion in 2025 to USD 29.66 billion by 2035 at a 9.20% CAGR, supported by expanding CGM adoption, automated insulin delivery, connected diabetes devices, and home-based disease management.
Read Report Details
The U.S. Diabetes Management Devices Market is projected to grow from USD 21.45 billion in 2025 to USD 59.20 billion by 2035 at a 10.69% CAGR, driven by CGM, automated insulin delivery, insulin pumps, connected devices, and expanding type 2 diabetes adoption.
Read Report Details